<?xml version="1.0" encoding="UTF-8"?>
<p>Through ethnobotanical screening, thousands of plants and their biologically active ingredients have been identified. Of the estimated 300,000 plants species that exist worldwide, only around 15% have been evaluated for their pharmacological activity [
 <xref rid="B4-molecules-26-00607" ref-type="bibr">4</xref>]. It is estimated that two-thirds of the worldâ€™s plant species have medicinal value [
 <xref rid="B5-molecules-26-00607" ref-type="bibr">5</xref>]. Between 1981 and 2019, the FDA approved more than 1500 drugs either made from unaltered natural products, botanical drug mixtures, derivates of natural products, synthetic drugs with pharmacophores from natural products or mimics of natural products [
 <xref rid="B6-molecules-26-00607" ref-type="bibr">6</xref>,
 <xref rid="B7-molecules-26-00607" ref-type="bibr">7</xref>]. In 2019, the FDA approved 441 small molecule drugs made directly from natural products and their derivates [
 <xref rid="B7-molecules-26-00607" ref-type="bibr">7</xref>]. Refer to 
 <xref rid="molecules-26-00607-t001" ref-type="table">Table 1</xref>.
</p>
